Tagrisso

Description

The drug Tagrisso is used as:

adjuvant therapy for non-small cell lung cancer in adult patients after complete resection of the tumor in the presence of a mutation in the EGFR gene in the tumor cells (deletion in exon 19 or substitution L858R in exon 21);
first line of treatment for locally advanced or metastatic non-small cell lung cancer in the presence of a mutation in the EGFR gene (deletion in exon 19 or substitution L858R in exon 21) in adult patients;
locally advanced or metastatic non-small cell lung cancer with the T790M mutation in the EGFR gene in adult patients.

Active ingredient: osimertinib

Prescription medicine